Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec;15(12):2044-2062.
doi: 10.1080/15548627.2019.1596489. Epub 2019 Mar 27.

PSEN2 (presenilin 2) mutants linked to familial Alzheimer disease impair autophagy by altering Ca2+ homeostasis

Affiliations

PSEN2 (presenilin 2) mutants linked to familial Alzheimer disease impair autophagy by altering Ca2+ homeostasis

Chiara Fedeli et al. Autophagy. 2019 Dec.

Abstract

PSEN2 (presenilin 2) is one of the 3 proteins that, when mutated, causes early onset familial Alzheimer disease (FAD) cases. In addition to its well-known role within the γ-secretase complex (the enzyme ultimately responsible for Aβ peptides formation), PSEN2 is endowed with some γ-secretase-independent functions in distinct cell signaling pathways, such as the modulation of intracellular Ca2+ homeostasis. Here, by using different FAD-PSEN2 cell models, we demonstrate that mutated PSEN2 impairs autophagy by causing a block in the degradative flux at the level of the autophagosome-lysosome fusion step. The defect does not depend on an altered lysosomal functionality but rather on a decreased recruitment of the small GTPase RAB7 to autophagosomes, a key event for normal autophagy progression. Importantly, FAD-PSEN2 action on autophagy is unrelated to its γ-secretase activity but depends on its previously reported ability to partially deplete ER Ca2+ content, thus reducing cytosolic Ca2+ response upon IP3-linked cell stimulations. Our data sustain the pivotal role for Ca2+ signaling in autophagy and reveal a novel mechanism by which FAD-linked presenilins alter the degradative process, reinforcing the view of a causative role for a dysfunctional quality control pathway in AD neurodegeneration.Abbreviations: Aβ: amyloid β; AD: Alzheimer disease; ACTB: actin beta; AMPK: AMP-activated protein kinase; APP: amyloid-beta precursor protein; BafA: bafilomycin A1; BAPTA-AM: 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid acetoxymethyl ester; CFP: cyan fluorescent protein; EGTA-AM: ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid acetoxymethyl ester; ER: endoplasmic reticulum; EGFP-HDQ74: enhanced GFP-huntingtin exon 1 containing 74 polyglutamine repeats; FAD: familial Alzheimer disease; FCS: fetal calf serum; FRET: fluorescence/Förster resonance energy transfer; GFP: green fluorescent protein; IP3: inositol trisphosphate; KD: knockdown; LAMP1: lysosomal associated membrane protein 1; MAP1LC3-II/LC3-II: lipidated microtubule-associated protein 1 light chain 3; MCU: mitochondrial calcium uniporter; MICU1: mitochondrial calcium uptake 1; MEFs: mouse embryonic fibroblasts; MFN2: mitofusin 2; MTOR: mechanistic target of rapamycin kinase; MTORC1: MTOR complex 1; SQSTM1/p62: sequestosome 1; PSEN1: presenilin 1; PSEN2: presenilin 2; RAB7: RAB7A: member RAS oncogene family; RFP: red fluorescent protein; ATP2A/SERCA: ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting; siRNA: small interference RNA; V-ATPase: vacuolar-type H+-ATPase; WT: wild type.

Keywords: ATP2A/SERCA; Alzheimer disease; ER-mitochondria tethering; RAB7; autophagosome-lysosome fusion; calcium; presenilin.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Expression of FAD-PSEN2 mutants blocks autophagy. (a) Representative western blot for LC3-I, LC3-II and PSEN2 (left) and quantification (right) of LC3-II basal levels (normalized to ACTB levels) in SH-SY5Y cells (control and PSEN2T122R-expressing). Mean ± SEM, n = 4 independent experiments. **p < 0.01. (b) Left, representative confocal images of SH-SY5Y cells (control and PSEN2T122R-expressing) co-transfected with a GFP-LC3 cDNA. Green dots represent autophagosomes at basal conditions. Scale bar: 10 µm. Right, quantification of GFP-LC3 dots in the different cell types. Mean ± SEM, n = 45 and 16 cells for control and PSEN2T122R-expressing, respectively, from 3 independent experiments. **p < 0.01. (c) SH-SY5Y cells (control and PSEN2T122R-expressing) were incubated for 1 h at 37°C with complete medium (DMEM + 10% FCS; fed) or with an extracellular solution supplemented with 1 mM CaCl2 (starv), in the absence or presence of BafA (100 nM). Endogenous LC3 (LC3-I and LC3-II) and PSEN2 levels are shown in a representative western blot (left) and levels of LC3-II (normalized to ACTB) are quantified in the different conditions (right). Mean ± SEM, n = 9 independent experiments. *p < 0.05; **p < 0.01. (d) SH-SY5Y cells (control and PSEN2T122R-expressing, co-transfected with mitochondrial RFP to select transfected cells) were treated as in (c) and immuno-stained for endogenous LC3. Representative confocal images (left) and LC3 dots quantification (right) are shown. Scale bar: 10 µm. Mean ± SEM, n = 60–90 cells, from 4 independent experiments. (e) Primary human fibroblasts (from a heathy control, and a FAD-PSEN2N141I subject; see Materials and Methods) were treated as in (c) and immuno-stained for endogenous LC3. Representative images (left) and LC3 dots quantification (right) are shown. Scale bar: 10 µm. Mean ± SEM, n = 18–29 cells, from 3 independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001.
Figure 2.
Figure 2.
Expression of FAD-PSEN2T122R induces a blocks in the autophagy flux. (a and b) SH-SY5Y cells (control or PSEN2T122R-expressing) transfected with cDNA for the mCherry-GFP-LC3 probe were (a) incubated, or not (not-treated, NT), with BafA (100 nM) for 8 h, or (b) left for 2 h in complete medium (fed) or extracellular saline (starv), and analyzed by confocal microscopy for GFP (Ex, 488 nm) and mCherry (Ex, 555 nm) fluorescence (see Fig. S4 for single fluorescence images). Representative confocal images (left) are shown; white dots represent GFP+, RFP+ vesicles, thus autophagosomes, while red dots represent autolysosomes. Scale bar, 10 µm. Histograms (right) represent white dot (GFP+, RFP+) quantification over total dots [(GFP+, RFP+) plus RFP+]. Mean ± SEM, n = 29–65 cells, from 3 independent experiments. ***p < 0.001. (c) Representative confocal images and relative quantification of SH-SY5Y cells (control or PSEN2T122R-expressing) transfected with the EGFP-HDQ74 cDNA and incubated, or not (not-treated, NT), with BafA (100 nM) for 2 h, as indicated. The percentage of cells displaying EGFP-HDQ74 aggregates (indicated by arrows) was calculated (right). Cells without aggregates are marked by dotted ROIs. Scale bar: 10 μm. Mean ± SEM, n = 90–230 cells from 3 independent experiments. *p < 0.05; **p < 0.01.
Figure 3.
Figure 3.
Expression of FAD-PSEN2 impairs autophagosome-lysosome fusion. (a) SH-SY5Y cells (control or PSEN2T122R-expressing, co-transfected with a nuclear CFP to select transfected cells) were incubated for 2 h with complete medium (fed) or extracellular saline (starv). Cells were immuno-stained for endogenous LC3 and LAMP1 (secondary Alexa Fluor 488 and Alexa Fluor 555 conjugated antibodies were used, respectively) and visualized by confocal microscopy. Merged images are shown (left) together with Manders’ M2 co-localization coefficient and the proportion of double positive LC3+LAMP1+ dots over total LC3+ dots (right), for each condition. Scale bar, 10 µm. Mean ± SEM, n = 30–37 cells, from 3 independent experiments. *p < 0.05; **p < 0.01. (b) Primary human fibroblasts (from a healthy and a FAD-PSEN2N141I subject) were incubated, or not (not-treated, NT), with BafA (100 nM) for 2 h, and immuno-stained for endogenous LC3 and LAMP1. Representative confocal images (left) and Manders’ M2 co-localization coefficient and the proportion of double positive LC3+LAMP1+ dots over total LC3+ dots (right) are presented for each condition. Scale bar, 10 µm. Mean ± SEM, n = 21–38 cells, from 3 independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001.
Figure 4.
Figure 4.
Expression of FAD-PSEN2 affects RAB7 recruitment to autophagic vesicles. (a and b) SH-SY5Y cells (control or PSEN2T122R-expressing, co-transfected with a mitochondrial RFP to select transfected cells) were incubated for 2 h with complete medium (fed) or extracellular saline (starv) and immuno-stained for endogenous RAB7 and LC3 (a) or endogenous RAB7 and LAMP1 (b). Secondary Alexa Fluor 488 and Alexa Fluor 647 conjugated antibodies were used, respectively. Single confocal images were collected separately and the merged ones (left) together with the Pearson’s co-localization coefficient and the proportion of double positive LC3+RAB7+ (or LAMP1+RAB7+) dots over total LC3+ (or LAMP1+) dots (right) are shown for each condition, as indicated. Scale bar, 10 µm. Mean ± SEM, n = 23–34 cells, from 3 independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001.
Figure 5.
Figure 5.
Autophagy flux is impaired by MFN2 ablation and PSEN2T122R expression. (a and b) MEFs (a) wt or (b) mfn2−/− (control or PSEN2T122R-expressing) were transfected with cDNA for the mCherry-GFP-LC3 probe and incubated, or not (not-treated, NT), with BafA (100 nM) for 8 h (left), or subjected, or not, to starvation for 2 h (right). Cells were then analyzed by confocal microscopy for GFP (Ex, 488 nm) and mCherry (Ex, 555 nm) fluorescence. Representative confocal images (white and red dots represent autophagosomes and autolysosomes, respectively) and quantification of white dots (GFP+RFP+) over total dots [(GFP+RFP+) plus RFP+] are shown. Scale bar, 20 µm. Mean ± SEM, n = 28–61 cells, from 3 independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001.
Figure 6.
Figure 6.
Partial depletion of ER Ca2+ content mimics the autophagy defect induced by FAD-PSEN2 expression. (a) Representative western blot (left) and quantification (right) of LC3 basal levels (normalized to ACTB) in SH-SY5Y cells (control or PSEN2T122R-expressing) transfected with scramble (scr-siRNA) or anti-ATP2A/SERCA (ATP2A/SERCA-siRNA) siRNAs. Mean ± SEM, n = 4 independent experiments. *p < 0.05; **p < 0.01. (b) Representative images and quantification of LC3 dots, revealed by immuno-staining, in SH-SY5Y cells transfected with the indicated siRNAs and treated, or not (not-treated, NT), with BafA (100 nM; 2 h). Mean ± SEM, n = 26–51 cells, from 3 independent experiments. ***p < 0.001. (c) Representative images and quantification of endogenous RAB7 and LC3-GFP co-localization (Pearson’s coefficient) in SH-SY5Y cells (control or PSEN2T122R-expressing) transfected as in (a) and incubated with complete medium (fed) or extracellular saline (starv) for 2 h. Mean ± SEM, n = 14–34 cells, from 3 independent experiments. *p < 0.05; **p < 0.01. (d) Quantification of LC3 dots, revealed by immuno-staining, in SH-SY5Y cells treated, or not (NT), with BAPTA-AM or EGTA-AM (5 µM) for 3 h, or EGTA (2 mM) over night (on), in the presence, or not, of BafA (100 nM). Mean ± SEM, n = 20–53 cells, from 3 independent experiments. ***p < 0.001.
Figure 7.
Figure 7.
Cytosolic Ca2+ signal is essential in mediating the autophagy defect induced by FAD-PSEN2 expression. (a) Representative images and quantification of LC3 dots, revealed by immuno-staining, in SH-SY5Y cells incubated, or not (control), with BAPTA-AM or EGTA-AM (2 μM, 1 h) and treated, or not (not-treated, NT) with BafA (100 nM). Mean ± SEM, n = 26–51 cells, from 3 independent experiments. *p < 0.05; ***p < 0.001. (b and c) SH-SY5Y cells were incubated with, or without (control), BAPTA-AM (2 μM) for 1 h in complete medium (fed) or extracellular saline (starv). Cells were immuno-stained for (b) endogenous RAB7 and LC3 or (c) endogenous RAB7 and LAMP1. Merged images (left) together with the Pearson’s co-localization coefficients (right) and the proportion of double positive LC3+RAB7+ (or LAMP1+RAB7+) dots over total LC3+ (or LAMP1+) dots are shown, for each condition. Scale bar, 10 µm. Mean ± SEM, n = 25–33 cells, from 3 independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001.
Figure 8.
Figure 8.
Mitochondrial Ca2+ signal is not involved in mediating FAD-PSEN2-induced autophagy defects. (a–c) Representative images and quantification of LC3 dots, revealed by immuno-staining, in SH-SY5Y cells, control or expressing the indicated proteins (PSEN2T122R and ATP2A/SERCA, (a); PSEN2T122R and MCU, (b); MICU1EFmut, (c)), and treated, or not (not-treated, NT) with BafA (100 nM; 2 h). Mean ± SEM, n = 18–23 cells, from 3 independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001.

References

    1. Menzies FM, Fleming A, Caricasole A, et al. Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities. Neuron. 2017;93:1015–1034. - PubMed
    1. Querfurth HW, LaFerla FM.. Alzheimer’s disease. N Engl J Med. 2010;362:329–344. - PubMed
    1. Nixon RA. Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer’s disease: inseparable partners in a multifactorial disease. FASEB J. 2017;31:2729–2743. - PMC - PubMed
    1. Cai Q, Tammineni P. Alterations in mitochondrial quality control in Alzheimer’s disease. Front Cell Neurosci. 2016;10:24. - PMC - PubMed
    1. Yu WH, Cuervo AM, Kumar A, et al. Macroautophagy–a novel Beta-amyloid peptide-generating pathway activated in Alzheimer’s disease. J Cell Biol. 2005;171:87–98. - PMC - PubMed

Publication types

MeSH terms